Media Coverage

Media Coverage

Read how VistaGen’s intention to revolutionize mental health medicine is causing a buzz in the media.

FierceBiotech logo image
VistaGen nabs phase 3-ready social anxiety drug from Pherin
Read
CNBC logo image
Ketamine is emerging as a popular treatment for depression. New research suggests the drug acts like an opioid
Read
Business Insider logo image
Stanford researchers are figuring out how ketamine fights depression — and why the drug has been called 'the most important discovery in half a century'
Read
Inc. logo image
24 Simple Ideas on How to Change Your Habits and Get More Done Today
Read
The Deal
VistaGen Working on Oral Ketamine-like Compound for Depression
Read
Outsourcing-Pharma logo image
Two US patents will help deliver ketamine-like antidepressant effects, says VistaGen
Read
Business Insider logo image
A depression drug that researchers have called 'the most important discovery in half a century' just got a big lift
Read
Business Insider logo image
Pharma giants are looking to ketamine for clues to the next blockbuster depression drug — and science says they're onto something big
Read
Chemistry World logo image
The K factor: How the party drug ketamine may hold the key to treating patients with severe depression
Read